Medinotec (MDNC) Change in Accured Expenses (2022 - 2023)

Medinotec (MDNC) reported Change in Accured Expenses of $7797.0 for Q4 2023, down 44.14% on a YoY basis from $13957.0 in Q4 2022, and down 2.17% quarter-over-quarter from $7970.0 in Q3 2023.

Medinotec (MDNC) Change in Accured Expenses (2022 - 2023) Analysis & Trends

Medinotec has reported Change in Accured Expenses for 2 years, with the latest figure at $7797.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -654.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 703.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -347.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 21.07 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 145.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -250.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 74.30 Mn
10 Medinotec - - 854,557.00 -

Historic Data

Download Data
DateValue
Nov 30, 2023 7,797.00
Nov 30, 2023 7,797.00
Aug 31, 2023 7,970.00
Aug 31, 2023 7,970.00
Nov 30, 2022 13,957.00
Nov 30, 2022 13,957.00
Aug 31, 2022 8,800.00
Aug 31, 2022 8,800.00